Filtered By:
Condition: Incontinence
Management: WHO

This page shows you your search results in order of date.

Order by Relevance | Date

Total 8 results found since Jan 2013.

Urinary incontinence - from childhood onwards
Acta Clin Croat. 2022 Mar;61(1):115-123. doi: 10.20471/acc.2022.61.01.14.ABSTRACTUrinary incontinence (UI) is a condition that affects patients of all ages, starting with childhood. There are two peaks in its incidence, i.e., in childhood and another one in patients over 40 years of age, which increases continuously with patient age. It is a condition recognized by the World Health Organization as a set of diseases (International Classification of Diseases, ICD-10), and the International Classification of Functionality recognizes the associated extreme disablement. UI is a major health problem affecting the lives of an est...
Source: Acta Clinica Croatica - November 18, 2022 Category: General Medicine Authors: Dragana Živković Damir Frani ć Vladimir Kojovi ć Source Type: research

Urinary incontinence - from childhood onwards
Acta Clin Croat. 2022 Mar;61(1):115-123. doi: 10.20471/acc.2022.61.01.14.ABSTRACTUrinary incontinence (UI) is a condition that affects patients of all ages, starting with childhood. There are two peaks in its incidence, i.e., in childhood and another one in patients over 40 years of age, which increases continuously with patient age. It is a condition recognized by the World Health Organization as a set of diseases (International Classification of Diseases, ICD-10), and the International Classification of Functionality recognizes the associated extreme disablement. UI is a major health problem affecting the lives of an est...
Source: Acta Clinica Croatica - November 18, 2022 Category: General Medicine Authors: Dragana Živković Damir Frani ć Vladimir Kojovi ć Source Type: research

Urinary incontinence - from childhood onwards
Acta Clin Croat. 2022 Mar;61(1):115-123. doi: 10.20471/acc.2022.61.01.14.ABSTRACTUrinary incontinence (UI) is a condition that affects patients of all ages, starting with childhood. There are two peaks in its incidence, i.e., in childhood and another one in patients over 40 years of age, which increases continuously with patient age. It is a condition recognized by the World Health Organization as a set of diseases (International Classification of Diseases, ICD-10), and the International Classification of Functionality recognizes the associated extreme disablement. UI is a major health problem affecting the lives of an est...
Source: Acta Clinica Croatica - November 18, 2022 Category: General Medicine Authors: Dragana Živković Damir Frani ć Vladimir Kojovi ć Source Type: research

Urinary incontinence - from childhood onwards
Acta Clin Croat. 2022 Mar;61(1):115-123. doi: 10.20471/acc.2022.61.01.14.ABSTRACTUrinary incontinence (UI) is a condition that affects patients of all ages, starting with childhood. There are two peaks in its incidence, i.e., in childhood and another one in patients over 40 years of age, which increases continuously with patient age. It is a condition recognized by the World Health Organization as a set of diseases (International Classification of Diseases, ICD-10), and the International Classification of Functionality recognizes the associated extreme disablement. UI is a major health problem affecting the lives of an est...
Source: Acta Clinica Croatica - November 18, 2022 Category: General Medicine Authors: Dragana Živković Damir Frani ć Vladimir Kojovi ć Source Type: research

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news

Management Protocols and Encountered Complications among Stroke Patients Admitted to Stroke Unit of Jimma University Medical Center, Southwest Ethiopia: Prospective Observational study
ConclusionBoth neurologic and medical complications were common in majority of stroke patients. But the management protocol for stroke patients was sub-optimal and lagging behind the recommended guidelines due to lack of skilled personnel, appropriate treatment and diagnostic agents. The clinical team involved in the care of stroke patients should make preparations to take preventive measures that will save a lot of lives.
Source: Annals of Medicine and Surgery - November 15, 2019 Category: General Medicine Source Type: research

Predictors of caregiver burden after stroke in Nigeria: Effect on psychosocial well-being.
Conclusion: In this study, psychosocial burden in CGs was indexed by various determinants and impacted QoL negatively. Given the integral role of CGs to the care of SSs in the community, mental health services, psychosocial support programs, and stratification based on known vulnerability factors seems viable options for intervention, assessment, and planning. PMID: 31579140 [PubMed]
Source: Indian Journal of Psychiatry - October 4, 2019 Category: Psychiatry Tags: Indian J Psychiatry Source Type: research

Psychiatric comorbidity and quality of life in patients with post-stroke emotional incontinence.
CONCLUSION: PSEI causes some aspects of psychiatric distress and negatively affects psychological and interpersonal quality of life. For patients with PSEI, special attention to psychiatric comorbidity and quality of life is needed, even in the acute stage of stroke. PMID: 24474987 [PubMed]
Source: Psychiatry Investigation - December 2, 2014 Category: Psychiatry Tags: Psychiatry Investig Source Type: research